Chondrosarcoma surgery: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
 
(14 intermediate revisions by 5 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Chondrosarcoma}}
{{Chondrosarcoma}}
{{CMG}}
 
{{CMG}}; {{AE}} {{Rohan}}


==Overview==
==Overview==
The predominant therapy for chondrosarcoma is surgical resection. Adjunctive [[chemotherapy]] and [[radiation]] may be required.
[[Surgery]] is the mainstay of treatment for chondrosarcoma. Adjunctive [[chemotherapy]] and [[radiation]] may be required. Recurrence rate depends on the grade of chondrosarcoma.


==Surgery==
==Surgery==
Because chondrosarcoma affects different parts of the body, the type of treatment depends on the size, location, and grade of the tumor. Musculoskeletal tumor Specialists or Orthopedic Oncologists are the most qualified to treat chondrosarcoma, unless it is located in the skull, spine, or chest cavity, in which case, a Neurosurgeon or Thoracic surgeon experienced with sarcomas would be needed.
*Surgery is the mainstay treatment for chondrosarcoma.<ref>{{cite book | last = Peabody | first = Terrance | title = Orthopaedic oncology : primary and metastatic tumors of the skeletal system | publisher = Springer | location = Cham | year = 2014 | isbn = 9783319073224 }}</ref><ref>{{cite book | last = Czerniak | first = Bogdan | title = Dorfman and Czerniak's bone tumors | publisher = Elsevier/Saunders | location = Philadelphia, PA | year = 2016 | isbn = 9780323023962 }}</ref><ref name="pmid30559960">{{cite journal| author=Lex JR, Evans S, Stevenson JD, Parry M, Jeys LM, Grimer RJ| title=Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment. | journal=Clin Sarcoma Res | year= 2018 | volume= 8 | issue=  | pages= 23 | pmid=30559960 | doi=10.1186/s13569-018-0110-1 | pmc=6293503 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30559960  }} </ref><ref name="pmid8608505">{{cite journal| author=Ozaki T, Lindner N, Hillmann A, Rödl R, Blasius S, Winkelmann W| title=Influence of intralesional surgery on treatment outcome of chondrosarcoma. | journal=Cancer | year= 1996 | volume= 77 | issue= 7 | pages= 1292-7 | pmid=8608505 | doi=10.1002/(SICI)1097-0142(19960401)77:7<1292::AID-CNCR10>3.0.CO;2-X | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=8608505  }} </ref><ref name="pmid11029557">{{cite journal| author=Marco RA, Gitelis S, Brebach GT, Healey JH| title=Cartilage tumors: evaluation and treatment. | journal=J Am Acad Orthop Surg | year= 2000 | volume= 8 | issue= 5 | pages= 292-304 | pmid=11029557 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11029557  }} </ref>
 
===Intra-Lesional Curettage===
'''Indications'''
*Grade 1 chondrosarcoma involving the [[extremities]].  
 
===Wide Surgical Excision===       
 
'''Indications'''
*Grade 2 or 3 chondrosarcoma anywhere in the body.
*Grade 1 chondrosarcoma in [[pelvis]].
 
===Wide Surgical Excision Combined with Multi-Agent Chemotherapy=== 
 
'''Indications'''
*Mesenchymal chondrosarcoma.
 
===Limb-salvage through Pelvic Resection with or without Reconstruction===
 
'''Indications'''
*Dedifferentiated chondrosarcoma involving the [[pelvis]].<ref name="pmid15523011">{{cite journal| author=Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH et al.| title=Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. | journal=J Bone Joint Surg Am | year= 2004 | volume= 86-A | issue= 11 | pages= 2412-8 | pmid=15523011 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15523011  }} </ref>
 
===Limb-sacrifice with Hindquarter Amputation===
 
'''Indications'''
*Dedifferentiated chondrosarcoma involving the [[pelvis]]<ref name="pmid15523011">{{cite journal| author=Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH et al.| title=Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes. | journal=J Bone Joint Surg Am | year= 2004 | volume= 86-A | issue= 11 | pages= 2412-8 | pmid=15523011 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15523011  }} </ref>


*Surgery is the main form of treatment for chondrosarcoma.
===Recurrence Rate===
*Treatment depends on the location of the disease and the aggressiveness of the tumors [http://www.cancerbacup.org.uk/Cancertype/Bone/Typesofbonecancer/Chondrosarcoma#3340].  Often, a limb-sparing operation can be performed[http://www.seattlecca.org/patientsandfamilies/adultCare/clinicalProgs/sarcoma/BoneCancerTreatmentOptions/LimbSparingSurgery.htm], however in some cases amputation is unavoidable.
*[[Amputation]] of the [[arm]], [[leg]], [[jaw]], or half of the [[pelvis]] (called a [[hemipelvectomy]]) may be necessary in some cases.
*There are two kinds of hemipelvectomy (internal and external):
**External hemipelvectomy is removal of that half of the pelvis with the [[amputation]] of the leg. It is also called the hindquarter amputation.
**Internal hemipelvectomy is removal of that half of the pelvis, but the leg is left intact.


*Even more rare are chondrosarcoma located in the skull base, spine, rib cage, or larynx. Complete surgical ablation is the treatment, but sometimes this is difficult. [[Proton therapy]] Radiation can be useful in these rare locations to make surgery more effective.
'''Grade 1 chondrosarcoma'''
*Follow up scans are extremely important for chondrosarcoma to make sure there has been no recurrence or [[metastasis]], which usually occurs in the lungs. Unlike other cancers, chondrosarcoma can return many years later.
*It is rare after wide [[resection]] with negative margins.
*5-15% is the recurrence rate after [[curettage]] with [[adjuvant treatment]].
 
'''Grade 2 chondrosarcoma'''
*The recurrence rate varies depending on [[resection]] margins.
 
'''Grade 3 chondrosarcoma'''
*The local recurrence rate is 25% and >30% chances of [[metastasis]].
{|
|[[File:Chondrosarcoma clinical image.gif|500px|thumb|Chondrosarcoma of glenoid and scapula. Source: Case courtesy by: [[User:Rohan Bhimani|Dr. Rohan A. Bhimani]]]]
|-
|}
<br style="clear:left" />


==References==
==References==
{{reflist|2}}
{{Reflist|2}}


[[Category:Disease]]
[[Category:Orthopedics]]
[[Category:Types of cancer]]
[[Category:Skeletal disorders]]


{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
[[Category:Up-To-Date]]
[[Category:Oncology]]
[[Category:Medicine]]
[[Category:Orthopedics]]

Latest revision as of 15:04, 13 March 2019

Chondrosarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Chondrosarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Chondrosarcoma surgery On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Chondrosarcoma surgery

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Chondrosarcoma surgery

CDC on Chondrosarcoma surgery

Chondrosarcoma surgery in the news

Blogs on Chondrosarcoma surgery

Directions to Hospitals Treating Chondrosarcoma

Risk calculators and risk factors for Chondrosarcoma surgery

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Rohan A. Bhimani, M.B.B.S., D.N.B., M.Ch.[2]

Overview

Surgery is the mainstay of treatment for chondrosarcoma. Adjunctive chemotherapy and radiation may be required. Recurrence rate depends on the grade of chondrosarcoma.

Surgery

Intra-Lesional Curettage

Indications

Wide Surgical Excision

Indications

  • Grade 2 or 3 chondrosarcoma anywhere in the body.
  • Grade 1 chondrosarcoma in pelvis.

Wide Surgical Excision Combined with Multi-Agent Chemotherapy

Indications

  • Mesenchymal chondrosarcoma.

Limb-salvage through Pelvic Resection with or without Reconstruction

Indications

  • Dedifferentiated chondrosarcoma involving the pelvis.[6]

Limb-sacrifice with Hindquarter Amputation

Indications

  • Dedifferentiated chondrosarcoma involving the pelvis[6]

Recurrence Rate

Grade 1 chondrosarcoma

Grade 2 chondrosarcoma

  • The recurrence rate varies depending on resection margins.

Grade 3 chondrosarcoma

  • The local recurrence rate is 25% and >30% chances of metastasis.
Chondrosarcoma of glenoid and scapula. Source: Case courtesy by: Dr. Rohan A. Bhimani


References

  1. ↑ Peabody, Terrance (2014). Orthopaedic oncology : primary and metastatic tumors of the skeletal system. Cham: Springer. ISBN 9783319073224.
  2. ↑ Czerniak, Bogdan (2016). Dorfman and Czerniak's bone tumors. Philadelphia, PA: Elsevier/Saunders. ISBN 9780323023962.
  3. ↑ Lex JR, Evans S, Stevenson JD, Parry M, Jeys LM, Grimer RJ (2018). "Dedifferentiated chondrosarcoma of the pelvis: clinical outcomes and current treatment". Clin Sarcoma Res. 8: 23. doi:10.1186/s13569-018-0110-1. PMC 6293503. PMID 30559960.
  4. ↑ Ozaki T, Lindner N, Hillmann A, Rödl R, Blasius S, Winkelmann W (1996). "Influence of intralesional surgery on treatment outcome of chondrosarcoma". Cancer. 77 (7): 1292–7. doi:10.1002/(SICI)1097-0142(19960401)77:7<1292::AID-CNCR10>3.0.CO;2-X. PMID 8608505.
  5. ↑ Marco RA, Gitelis S, Brebach GT, Healey JH (2000). "Cartilage tumors: evaluation and treatment". J Am Acad Orthop Surg. 8 (5): 292–304. PMID 11029557.
  6. ↑ 6.0 6.1 Dickey ID, Rose PS, Fuchs B, Wold LE, Okuno SH, Sim FH; et al. (2004). "Dedifferentiated chondrosarcoma: the role of chemotherapy with updated outcomes". J Bone Joint Surg Am. 86-A (11): 2412–8. PMID 15523011.


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Chondrosarcoma_surgery&oldid=1557837"